Analyse av intervjuene i Renaa Restauranter

-Verificamos aumento nos marcadores de hiperandrogenismo, resistência à insulina, lipídios séricos e citocinas inflamatórias em mulheres com SOP quando comparado á mulheres controles, conferindo-lhes pior perfil de risco cardiometabólico;

- O pronunciado aumento do dano de DNA nas mulheres com SOP, não foi confirmado em nossa amostra, permanecendo o grupo SOP e o controle com genotoxicidades semelhantes;

- A intervenção dietética reduziu o peso, o IMC, a resistência à insulina, melhorou o perfil lipídico e o hiperandrogenismo nas mulheres com SOP sobrepeso ou obesas, reduzindo o risco cardiometabólico nessas mulheres;

- A intervenção dietética reduziu a genotoxicidade de mulheres com SOP sobrepeso ou obesas.

Assim é possível sugerir que a incorporação de práticas que busquem minimizar a obesidade e melhorar o padrão de consumo alimentar utilizando-se de alimentação saudável, além de serem alternativas de tratamento para redução dos fatores de risco cardiometabólico, também pode configurar uma importante terapêutica para redução da genotoxicidade, conferindo assim, um efeito protetor ao organismo das mulheres acometidas pela SOP.

A partir desses resultados buscaremos investigar, com futuros estudos, quais práticas ou alimentos consumidos, podem influencia na redução da genotoxicidade na SOP, para assim, identificar um padrão alimentar ideal de consumo que minimizem os efeitos maléficos causados pela síndrome e propor condutas que possibilitem uma proteção genômica a essas mulheres.

REFERENCIAS

AKAMINE EH et al. Obesity induced by high-fat diet promotes insulin resistance in the ovary. Journal of Endocrinology, n. 206, p.65–74, 2010.

ALVAREZ-BLASCO F, et al.. Prevalence and characteristics of the polycystic ovary syndrome in overweight and obese women. Arch Intern Med, v.19, n.166, p.2081- 2086, 2006.

AMATO P and SIMPSON JL.The genetics of polycystic ovary syndrome. Best Practice and Research. Clinical Obstetrics and Gynaecology. v.18, p. 707–718, 2004.

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS. Medical guidelines for clinical practice for the diagnosis and treatment of hyperandrogenic disorders. Endocr Practice. v. 7, p. 121-134, 2001.

AMERICAN DIABETES ASSOCIATION. Standards of medical care in diabetes. Diabetes Care, v. 38 v. 1, p. S1-94, 2015.

ANDERSEN, P. et al. Increased insulin sensitivity and fibrinolytic capacity after dietary intervention in obese women with polycystic ovary syndrome. Metabolism, v. 44, p.611–616, 1995.

ASEMI Z, et al. Effects of DASH diet on lipid profiles and biomarkers of oxidative stress in overweight and obese women with polycystic ovary syndrome: a randomized clinical trial. Nutrition. v.30, n.11, p.1287-1293, 2015.

AZEVEDO MF, et al. Elevated blood pressure in women with polycystic ovary syndrome: prevalence and associated risk factors. Rev Bras Ginecol Obstet v.33.p.31- 36, 2011.

AZZIZ R, et al. The prevalence and features of the polycystic ovary syndrome in an unselected population.J Clin Endocrinol Metabol. v. 89, n. 27, p. 45-59, 2004.

AZZIZ, R. Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature. J Clin Endocrinol Metab, v. 91, n. 3, p. 781-785, 2006.

AZZIZ R, et al. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril. v.91, p.456-488, 2009. BAHMANI F, et al. The effects of folate supplementation on inflammatory factors and biomarkers of oxidative stress in overweight and obese women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled clinical trial. Clin Endocrinol (Oxf).v.81, n.4, p.582-587, 2014.

BAIRD DT, et al. Health and fertility in World Health Organization group 2 anovulatory women. ESHRE Capri Workshop Group. Hum Reprod Update.v.18, n.5, p.586-99, 2012.

BENASSI-EVANS B, et al. High-protein/high red meat and high-carbohydrate weight- loss diets do not differ in their effect on faecal water genotoxicity tested by use of the

WIL2-NS cell line and with other biomarkers of bowel health.Mutat Res.v. 703, n.2, p.130-136, 2010.

BASTIANETTO S, et al. Dehydroepi-androsterone (DHEA) protects hippocampalcells from oxidative stress-induced damage. Brain Res Mol Brain Res. v.66, p.31–5, 1999. BIANCHI M.L;ANTUNES L.M.G. Radiacais livre e os principais antioxidantes da dieta. Rev. Nutr. v.12, n.2, p.123-130, 1999.

BISHOP KS. et al. An investigation into the association between DNA damage and dietary fatty acid in men with prostate cancer. Nutrients. n.7, p.405-422, 2015

BLAIR SA, et al. Oxidative stress and inflammation in lean and obese subjects with polycystic ovary syndrome. J Reprod Med. v. 58, p.107-114, 2013.

BRAND-MILLER JC, THOMAS M, SWAN V. Physiological validation of the concept of glycemic load in lean young adults. J Nutr. v.133p.2728–32, 2003

BRASIL. Ministério da Saúde. Secretaria de Atenção à Saúde. Departamento de Atenção Básica. Guia alimentar para a população brasileira / Ministério da Saúde, Secretaria de Atenção à Saúde, Departamentode Atenção Básica. – 1. ed. – Brasília : Ministério da Saúde, 2006.

BRASIL. Ministério da Saúde. Secretaria de Atenção à Saúde. Departamento de Atenção Básica. Guia alimentar para a população brasileira / Ministério da Saúde, Secretaria de Atenção à Saúde, Departamentode Atenção Básica. – 2. ed. – Brasília : Ministério da Saúde, 2014.

BRIGNARDELLO E, et al. Dehydroepiandrosterone administration counteracts oxidative imbalance and advanced glycation end product formation in type 2 diabetic patients. Diabetes Care. v.30, n.11, p.2922-7, 2007

CAKIR E, et al. Oxidative stress markers are not valuable markers in lean and early age of polycystic ovary syndrome patients. J Endocrinol Invest.v. 34, p.178-182, 2011 CALLE EE & KAAKS R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat. Rev. Cancer.2004; 4:579–591.

CANCELLO R, et al. Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery- induced weight loss. Diabetes., v. 54, p. 2277–2286, 2005.

CARMINA E et al. Difference in body weight between American and Italian women with polycystic ovary syndrome: influence of the diet. Hum Reprod. v.18, p. 2289– 2293, 2003.

CARMINA E, et al. Metabolic syndrome in polycystic ovary syndrome (PCOS): lower prevalence in southern Italy than in the USA and the influence of criteria for the diagnosis of PCOS. Eur J Endocrinol. v.154, n. 1, p. 141–145, 2006.

CARMINA E, LOBO R. Use of fasting blood to assess the prevalence of insulin resistance in women with polycystic ovary syndrome.Fertil Steril. v.82, n. 3, p.661– 665,2004.

CASES J, et al. Regular consumption of Fiit-ns, a polyphenol extract from fruit and vegetables frequently consumed within the Mediterranean diet, improves metabolic ageing of obese volunteers: a randomized, double-blind, parallel trial. Int J Food Sci Nutr. v.66, n.1, p.120-5, 2015.

CHANG RJ, et al. Insulin resistance in nonobese patients with polycystic ovarian disease J Clin Endocrinol Metab., v.57, p. 356-369, 1983.

CHAPMAN MJ, SPOSITO AC. Hypertension and dyslipidaemia in obesity and insulin resistance: pathophysiology, impact on atherosclerotic disease and pharmacotherapy. Pharmacol Ther. v. 117, n. 3, p.354-373, 2008.

CHITTENDEN BG, et al Polycystic ovary syndrome and the risk of gynaecological cancer: a systematic review. Reprod Biomed Online. v.19, n.3, p.398-405, 2009. COHEN, J. Statistical power analysis for the behavioral sciences. Hillsdale, NJ: Erlbaum, 1988.

COLLINS AR, et al. Nutritional modulation of DNA repair in a human intervention study. Carcinogenesis.v.24,p.511–515, 2003

COSTA EC, et al. Anthropometric indices of central obesity how discriminators of metabolic syndrome in Brazilian women with polycystic ovary syndrome. Gynecol Endocrinol.v.28, n.1, p.12-5, 2012.

COSTA L, VIANA A, OLIVEIRA M. Prevalência da síndrome metabólica em portadoras da síndrome dos ovários policísticos. Rev Bras Ginecol Obs. v. 29, n. 1, p.10–17,2007.

COSTA, E. C. et al. Central obesity index and cardiovascular risk factors in polycystic ovary syndrome. Arq Bras Cardiol, v. 94, n. 5, p. 633-638, 2010.

COSTA,R.M.A et al. The eukaryotic nucleotide excision repair pathway. Biochimie.v. 85,p. 1083-1099,2003.

CROSIGNANI PG, et al. Overweight and obese anovulatory patients with polycystic ovaries: parallel improvements in anthropometric indices, ovarian physiology and fertility rate induced by diet. Hum Reprod. v.18, p.1928–1932, 2003.

CUSSONS AJ, et al. Omega-3 fatty acid supplementation decreases liver fat content in polycystic ovary syndrome: a randomized controlled trial employing proton magnetic resonance spectroscopy. Clin Endocrinol Metab . v.94, n.10, p.3842-8, 2009.

DE SOUZA-JÚNIOR JE, et al. Polycystic ovary syndrome: aggressive or protective factor for the retina? Evaluation of macular thickness and retinal nerve fiber layers using high-definition optical coherence tomography. J Ophthalmol. 2015.

DELIGEOROGLOU E et al. Mediators of chronic inflammation in polycystic ovarian syndrome. Gynecol Endocrinol. v. 19, n. 2, p.20–27, 2012.

DESAI V, et al. Oxidative stress in non-obese women with polycystic ovarian syndrome.J Clin Diagn Res. v.8, n.7, 301-3, 2014.

DEUGARTE CM, BARTOLUCCI AA, AZZIZ R. Prevalence of insulin resistance in polycystic ovary syndrome using the homeostasis model assessment. Fertil Steril. v. 83, n. 5, p.1454-1460, 2005.

DIAMANTI-KANDARAKIS E. Role of obesity and adiposity in polycystic ovary syndrome. Int J Obes (Lond).v.31, n. 2, p.08-13, 2007.

DINGER Y, et al. DNA damage, DNA susceptibility to oxidation and glutathione level in women with polycystic ovary syndrome. Scand J Clin Lab Invest.v.65, n.8, p.721- 8, 2005.

DIZDAROGLU M. Chemical determination of free radical-induced damage to DNA.Free Radic Biol Med; v.10, p.225-242, 1991

DOKRAS A, et al. Screening Women With Polycystic Ovary.Obstet Gynecol. v.106, n.1, p.131-137, 2005.

DO MD et al. Metallothionein gene expression. In human adipose tissue from lean and obese subjects. Horm Metab Res. v.34, n.6,p.348-51, 2002.

DONMEZ-ALTUNTAS H, et al. Evaluation of chromosomal damage, cytostasis, cytotoxicity, oxidative DNA damage and their association with body-mass index in obese subjects. Mutat Res Genet Toxicol Environ Mutagen. v.1, n.771, p.30-6, 2014. DRAGSTED LO, et al. Biological effects of fruit and vegetables. Proc Nutr Soc.v.65, p.61, 2006.

DULEBA AJ, DOKRAS A, Is PCOS an inflammatory process? Fertility and Sterility, v. 97, n. 1,p. 150-282, 2012.

DUNAIF A, et al. Clinical, biochemical, and ovarian morphologic features in women with acanthosis nigricans and masculinization. Obstet Gynecol. v. 66, p.545-52, 1985. DUNAIF A.et al Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev, v.18, p. 774-800, 1997.

DUNAIF, A et al. HYPERANDROGENIC ANOVULATION (PCOS). A unique disorder of insulin action associated with an increased risk of non-insulin-dependent diabetes mellitus. Am J Med., v.98, n.1A, p. 335-395, 1995.

EHRMANN DA. Polycystic ovary syndrome. Engl J Med. v.352, p.1223–1236, 2005. EHRMANN et al. Effects of Race and Family History of Type 2 Diabetes on Metabolic Status of Women with Polycystic Ovary Syndrome.J Clin Endocrinol Metab., v.90, n. 1, p.66–71, 2005.

EHRMANN, D. A. et al. Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab., v. 91, n. 1, p. 48- 53, 2006.

EHRMANN, D.A. Polycystic ovary syndrome Quick and comprehensive review on PCOS.N. Engl. J. Med. v. 352, p. 1223–1236, 2005.

ESCOBAR-MORREALE HF, et al. Serum interleukin-18 concentrations are increased in the polycystic ovary syndrome: relationship to insulin resistance and to obesity. J Clin Endocrinol Metab., v. 89, p. 806–811, 2004.

ESCOBAR-MORREALE HF, et al. Obesity, and not insulin resistance, is the major determinant of serum inflammatory cardiovascular risk markers in pre-menopausal women. Diabetologia., v. 46, p. 625–633, 2003.

ESCOBAR-MORREALE HF, et al. The molecular-genetic basis of functional hyperandrogenism and the polycystic ovary syndrome. Endocrine Reviews. v. 26, p.251–282, 2005.

EVANS MD, COOKE MS. Oxidative damage to DNA in non-malignant disease: biomarker or biohazard? Genome Dyn. v.1, p.53-66, 2006.

FAUSER BC, et al. Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril. v.97, n.1, p.28-38, 2012.

FERNÁNDEZ-SÁNCHEZ A, MADRIGAL-SANTILLÁN E, BAUTISTA M. Inflammation, oxidative stress, and obesity. Int J Mol Sci. v.12, p.3117-32, 2011. FENECH M, et al. The Human Micronucleus Project-An international collaborative study on the use of the micronucleus technique for measuring DNA damage in humans. Mutat Res.v.428, p.271–283,1999.

FENECH M. The Genome Health Clinic and Genome Health Nutrigenomics concepts: diagnosis and nutritional treatment of genome and epigenome damage on an individual basis, Mutagenesis.v.20, p.255–269, 2005.

FENKCI V., et al. Decreased total antioxidant status and increased oxidative stress in women with polycystic ovary syndrome may contribute to the risk of cardiovascular disease, Fertil. Steril. v.80, p.123–127, 2003.

FERREIRA JAS, et al. Síndrome da anovulação crônica hiperandrogênica e transtornos psíquicos. Rev. Psiq. Clín. v.33, n.3, p.145-151, 2006.

FOOD AND AGRICULTURE ORGANIZATION/WORLD HEALTH

ORGANIZATION/UNITED NATIONS UNIVERSITY (FAO/OMS). Human Energy Requirements.Technical Report Series. p. 35-52, 2001.

FORSYTHE LK, WALLACE JM,LIVINGSTONE MB. Obesity and inflammation: the effects of weight loss. Nutr Res Rev., v. 21, p. 117–133, 2008.

FRIEDBERG,E. et al. DNA repair and mutagenesis.Washington: American Society of Microbiology Press; 2nd Edition. p.1118, 2006.

FRIEDEWALD, W.T.; LEVY, R.I.; FREDRICKSON, D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical Chemistry. v. 18, n. 6, p. 499-502, 1972.

GALLAGHER TF, et al. Adrenocortical hyperfunction in idiopathic hirsutism and the Stein-Leventhal syndrome. J Clin Invest., v.57, p. 794, 1958.

GALLO M, et al. Protective effect ofdehydroepiandrosterone against lipid peroxidation in human liver cell line. Eur J Endocrinol;v.141, p.35–9, 1999.

GAZIEV AI, et al. Effect of vitamin-antioxidant micronutrients on the frequency of spontaneous and in vitro gamma-ray-induced micronuclei in lymphocytes of donors: the age factor. Carcinogenesis. v.17, p.493-499, 1996.

GELONEZE, B. et al. The threshold value for insulin resistance (HOMA-IR) in an admixtured population IR in the Brazilian Metabolic Syndrome Study.Diabetes Res Clin Pract, v. 72, n. 2, p. 219-220, 2006.

GEORGE TW, et al.Effects of chronic consumption of fruit and vegetable puree-based drinks on vasodilation, plasma oxidative stability and antioxidant status. J Hum Nutr Diet. v. 25,n.5, p.477-87, 2012.

GHOSH, P. et al. Increased chromosome aberration frequencies in the Bowen’s patients compared to non-cancerous skin lesions individuals exposed to arsenic. Mutat Res. v.632, p.104–110, 2007.

GLUECK C., et al. Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome. Metabolism., v. 52, n. 7. p.908– 915, 2003.

GOGIA A. APK. Metabolic syndrome. Indian J Med Sci. v.60, n. 2, p. 72–81, 2006. GOSS AM, et al. Effects of a eucaloric reduced-carbohydrate diet on body composition and fat distribution in women with PCOS. Metabolism. v.63, n.10, p.1257-64, 2014. GONZÁLEZ F , et al. Hyperandrogenism exerts an anti-inflammatory effect in obese women with polycystic ovary syndrome , Endocrine. v. 30, n. 1, p. 52–61, 2012.

GONZALEZ F, et al. Hyperglycemia Alters Tumor Necrosis Factor Release from Mononuclear Cells in Women with ´Polycystic Ovary Syndrome. The Journal of Clinical Endocrinology & Metabolism. v. 90, n. 9, p.5336–5342, 2005.

GONZALEZ F, et al. Reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome. J Clin Endocrinol Metab.v.91, p. 336–340, 2006.

GOODARZI, M. O. et al. Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol, v. 7, n. 4, p. 219-231, 2011.

GONTIJO, R. TICE, Teste do cometa para detecção de dano no DNA e reparo em células individualizadas, in: Ulbra (Ed.), Mutagênese Ambiental. Canoas (RS), 2003; 10: 247–279.

GOODMAN, N. F. et al. American Association of Clinical Endocrinologists medical guidelines for the clinical practice for the diagnosis and treatment of hyperandrogenic disorders.Endocr Pract, v. 7, n. 2, p. 120-134, 2001.

GRAY K, et al. Effects of DNA damage in smooth muscle cells in atherosclerosis. Circ Res. v.116, n.5, p.816-26, 2015.

HAMURCU Z, et al. Micronucleus frequency in lymphocytes and 8- hydroxydeoxyguanosine level in plasma of women with polycystic ovary syndrome. Gynecol Endocrinol.v.26:p.590-595, 2010.

HAOULA Z. SALMAN M., ATIOMO W. Evaluating the association between endometrial cancer and polycystic ovary syndrome. Hum Reprod. v.27, p.1327– 1331,2012.

HEILBRONN LK, et al. Effect of 6-month calorie restriction on biomarkers of longevity, metabolic adaptation, and oxidative stress in overweight individuals: a randomized controlled trial. JAMA. v.295,n.13, p.1539-1548, 2006.

HOEGER KM. Role of lifestyle modification in the management of polycystic ovary syndrome best pract . Res Clin Obstet Gynaecol. v. 20, p. 293–310, 2006.

HOFER T, et al. Long-term effects of caloric restriction or exercise on DNA and RNA oxidation levels in white blood cells and urine in humans.Rejuvenation Res. v. 11, n.4, p.793-799, 2008.

HOLTE J, et al. Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab. v. 80, p. 2586–2593, 1995.

HULSMANS M, HOLVOET P. The vicious circle between oxidative stress and inflammation in atherosclerosis. J Cell Mol Med. v. 14, p.70–78, 2010.

HUNG HC, et al. Fruit and vegetable intake and risk of major chronic disease. J Natl Cancer Inst. v.96, p.1577–84, 2004.

HYDERALI BN & MALA K. Oxidative stress and cardiovascular complications in polycystic ovarian syndrome. Eur J Obstet Gynecol Reprod Biol.v.191, p.15-22, 2015 JOSHIPURA KJ, et al. Intakes of fruits, vegetables and carbohydrate and the risk of CVD. Public Health Nutr. v.12, p.115–21, 2009.

KAMMANN U, et al. A permanent fish cell line (EPC) for genotoxicity testing of marine sediments with the comet assay. Mutat Res. v.15, n.498, p.67-77, 2001.

KANDARAKIS ED, et al. Defects in insulin signaling pathways in ovarian steroidogenesis and other tissues in polycystic ovary syndrome (PCOS). Journal of Steroid Biochemistry & Molecular Biology.v.109, p. 242–246, 2008.

KANG SH, et al. Recent Advances in In Vivo Genotoxicity Testing: Prediction of Carcinogenic Potential Using Comet and Micronucleus Assay in Animal Models. J Cancer Prev.v.18, n.4, p.277–288, 2013

KARIHTALA, P, SOINI, Y. Reactive oxygen species and antioxidant mechanisms in human tissues and their relation to malignancies. APMIS, v. 115, p. 81-103, 2007. KATHIRESAN S et al. Increased small low-density lipoprotein particle number: a prominent feature of the metabolic syndrome in the Framingham Heart Study. Circulation.v.113, n.1, p.20-9, 2006.

KIM J, Choi YM. Dyslipidemia in women with polycystic ovary syndrome. Obstet Gynecol Sci. v.56, n.3,p.137-42, 2013.

KIRALY O, et al. Inflammation-induced cell proliferation potentiates DNA damage- induced mutations in vivo. PLoS Genet. v.3,n.11,p.2, 2015

KRYSTON TB, et al. Role of oxidative stress and DNA damage in human carcinogenesis. Mutat Res.v.711, p.193–201, 2011.

KUO LJ, YANG LX. Gamma-H2AX - a novel biomarker for DNA double-strand breaks. In Vivo. v.22, n.3, p.305-9, 2008.

KURDOGLU Z, et al. I. Oxidative status and its relation with insulin resistance in young non-obese women with polycystic ovary syndrome. J Endocrinol Invest.v. 35, p.317-321, 2012.

LEGRO RS. et al. Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2013.

LEGRO, R. S. et al. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab, v. 84, n. 1, p. 165-179, 1999. LIU J & ZHANG D. The role of oxidative stress in the pathogenesis of polycystic ovary syndrome. Sichuan Da XueXueBao Yi Xue Ban.v.43, p.187-190, 2012

LIU S, et al. Fruit and vegetable intake and risk of cardiovascular disease: the Women’s Health Study. Am J Clin Nutr.v.72, p.922–8, 2000.

LIU S, NAVARRO G, MAUVAIS-JARVIS F. Androgen excess produces systemic oxidative stress and predisposes to beta-cell failure in female mice. PLoS One. v.5. 2010.

LIVADAS S, DIAMANTI-KANDARAKIS E. Polycystic ovary syndrome: Definitions, phenotypes, and diagnostic approach. Front Horm Res., v.40, p.1-21, 2013.

LYKKESFELDT, J. Malondialdehyde as biomarker of oxidative damage to lipids caused by smoking. Clínica Chimica Acta. v. 380, n.1-2, p. 50-58, 2007.

MARCH WA et al. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod. v.25, p.544-551, 2010.

MARSH KA, et al. Effect of a low glycemic index compared with a conventional healthy diet on polycystic ovary syndrome. Am J Clin Nutr. v. 92, p. 83–92, 2010. MARTINS WP, et al. Agreement among insulin sensitivity indexes on the diagnosis of insulin resistance in polycystic ovary syndrome and ovulatory women. Eur J Obstet Gynecol Reprod Biol. v.133, n. 2, p. 203-207, 2007.

MATFIN G. Distúrbios do fluxo sanguíneo na circulação sistêmica.In: Porth CM, Matfin G. Fisiopatologia.8.ed.v.1.Rio de Janeiro: Guanabara Koogan. p.489-516, 2010

MEHRABANI HH, et al. Beneficial effects of a high-protein, low-glycemic-load hypocaloric diet in overweight and obese women with polycystic ovary syndrome: a randomized controlled intervention study. J Am Coll Nutr. v. 31, p. 117–125, 2012. MELO A, et al. Mulheres com síndrome dos ovários policísticos apresentam maior frequência de síndrome metabólica independentemente do índice de massa corpóreo; Women. Rev bras ginecol.v.34,n.1, p.4–10,2012.

MÍDIO, A. F.; MARTINS, D. I. Toxicologia de Alimentos. São Paulo: Varela. P. 295, 2000.

MITJAVILA MT, et al.The Mediterranean diet improves thesystemic lipidand DNA oxidativedamage in metabolic syndrome individuals. A randomized, controlled, trial.Clin Nutr.v.32,p.172-178, 2013.

MOHAMADIN AM, HABIB FA & ELAHI TF. Serum antioxidant vitamins changes in women with polycystic ovary syndrome. Pathophysiology.v. 17,p.189-96,2010.

MORAN C, et al. Adrenal androgen excess and body mass index in polycystic ovary syndrome. J Clin Endocrinol Metab.v.100, n. 3, p.942-950, 2015.

MORAN LJ, et al. Dietary Composition in the Treatment of Polycysticvary Syndrome: A Systematic Review to Inform Evidence-Based Guidelines. J AcadNutr Diet. v. 113, p. 520-545, 2013.

MORAN LJ, et al. Genome instability is increased in lymphocytes of women with polycystic ovary syndrome and is correlated with insulin resistance. Mutat Res.v.639, p.55-63, 2008.

MORAN LJ, et al. Dietary Composition in Restoring Reproductive and Metabolic Physiology in Overweight Women with Polycystic Ovary Syndrome. J Clin Endocrinol Metab.v.88, p. 812-819, 2003.

MORAN LJ, et al. Sleep disturbances in a community-based sample of women with polycystic ovary syndrome. Hum Reprod.v.30, n. 2, p. 466-72, 2015.

MUKHERJEE S, MAITRA A. Molecular & genetic factors contributing to insulin resistance in polycystic ovary syndrome. Indian J Med Res. v.131, p.743-760, 2010. MÜLLNER E, et al. Vegetables and PUFA-rich plant oil reduce DNA strand breaks in individuals with type 2 diabetes. Mol Nutr Food Res. v. 57, n.2, p.328-338, 2013. MURRI M, et al. Changes in oxidative stress and insulin resistance in morbidly obese patients after bariatric surgery. Obes Surg.v.20,p.363-368,2010

MURRI M, et al. Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): a systematic review and meta-analysis. Hum Reprod Update. v.19,p.268-288, 2013.

NAVARRO SD, et al. Resistant starch: a functional food that prevents DNA damage and chemical carcinogenesis. Genet Mol Res. v.14,p.1679-1691, 2015

NERSESYAN A, CHOBANYAN N. Micronuclei and other nuclear anomalies levels in exfoliated buccal cells and DNA damage in leukocytes of patients with polycystic ovary syndrome. J Buon.v.15, n.2, p.337-9, 2010.

NERSESYAN A, et al. Chromosomal aberrations level in peripheral blood lymphocytes of women with polycystic ovary syndrome. J Buon.v.11n.4,p.477-480, 2006.

NORMAN RJ, et al. Lifestyle Choices, Diet, and Insulin Sensitizers in Polycystic Ovary Syndrome. Endocrine. v. 30, p.35-43, 2006.

NYBACKA, A. et al. Randomized comparison of the influence of dietary management and/or physical exercise on ovarian function and metabolic parameters in overweight

In document Service Recovery (sider 38-43)